Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Methylnaltrexone bromide by Bausch Health for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
Methylnaltrexone bromide is under clinical development by Bausch Health and currently in Phase II for Head And Neck Squamous Cell...